While the company is showing early signs of recovery and margin improvement, a high valuation means risks remain.

Exercising during chemotherapy and before surgery may help the body send more immune cells into cancerous tumors, according ...

The letter addresses the termination of 2,100 research grants valued at more than $12 billion and some of the human costs ...

With the FDA approval of retifanlimab (Zynyz; Incyte) as the first and only first-line treatment for advanced anal cancer, researchers are now focusing on resistance mechanisms and future therapies, ...

A breakthrough study from Keck Medicine of USC may have found a powerful new triple therapy for glioblastoma, one of the deadliest brain cancers. By combining Tumor Treating Fields (TTFields), which ...

It’s a truth that all clinical teams are aware of: risk mitigation is a core part of clinical trial success. But, what does ...

A groundbreaking telehealth trial offers remote access to innovative pancreatic cancer treatment, enhancing patient ...

China Medical University Hospital (Taiwan) and Shine-On Biomedical Co. developed SOB100, the world's first HLA-G targeted ...

MEDSIR announces positive results from TUXEDO-3 trial of patritumab deruxtecan in patients with active brain metastases and leptomeningeal disease: Chicago Monday, June 9, 2025, 1 ...

Dr. Chung brings over three decades of experience spanning clinical ophthalmology, academic research and gene therapy developmentLONDON and CAMBRIDGE, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- Beacon T ...

Beacon Therapeutics recently announced positive six-month interim safety and efficacy results from the Phase 2 DAWN trial of ...

A migraine drug commonly used to treat headache pain may also alleviate the early, non-pain symptoms that often precede a ...